Raymond James Financial Services Advisors, Inc. Amarin Corp Plcuk Put Options Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

Put Options

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$1.13 - $3.69 $2,824 - $9,225	-2,500 Reduced 12.63%	17,300 $69,000
Q4 2021 Feb 08, 2022	SELL	$3.24 - $5.18 $21,708 - $34,706	-6,700 Reduced 25.28%	19,800 $37,000
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $45,270 - $79,200	9,000 Added 51.43%	26,500 $20,000
Q3 2020 Nov 04, 2020	SELL	$3.64 - $7.76 $56,784 - $121,056	-15,600 Reduced 47.13%	17,500 $316,000
Q2 2020 Jul 17, 2020	SELL	$4.78 - $8.26 $361,846 - $625,282	-75,700 Reduced 69.58%	33,100 $525,000
Q1 2020 Apr 21, 2020	BUY	$4.0 - $21.53 $335,600 - $1.81 Million	83,900 Added 336.95%	108,800 $1.96 Million
Q4 2019 Feb 12, 2020	BUY	$13.94 - $24.12 $103,156 - $178,488	7,400 Added 42.29%	24,900 $63,000
Q3 2019 Nov 07, 2019	BUY	$13.89 - $23.16 $44,448 - $74,112	3,200 Added 22.38%	17,500 $72,000
Q2 2019 Aug 06, 2019	SELL	$16.27 - $20.51 $188,732 - $237,916	-11,600 Reduced 44.79%	14,300 $12,000
Q1 2019 May 06, 2019	SELL	$12.61 - $22.33 $44,135 - $78,155	-3,500 Reduced 11.9%	25,900 $14,000
Q4 2018 Feb 11, 2019	BUY	$12.41 - $22.98 $364,854 - $675,612	29,400 New	29,400 $174,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$12.4 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$6.21 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.65 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.27 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.25 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account